Why Bristol-Myers Failure Is a Huge Win for Merck
Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was a big win for Merck.
All Work
Chris Lange
How Hortonworks Earnings Fell Flat
Hortonworks second-quarter earnings report sent shares down by nearly a third, even though the results were only slightly off.
Mixed FireEye Earnings Fail to Impress Investors
Although FireEye had a less-than-favorable quarter, management believes that the company is on the path to optimizing its cost structure.
Is This Earnings Report the Turning Point for Square?
Square, Inc. (NYSE: SQ) reported second-quarter financial results after the markets closed on Wednesday. The mobile-payments company posted incredible results for the quarter and shareholders were quick to applaud these numbers, initially sending the…
What Expect From Teva Earnings
Teva Pharmaceutical Industries is scheduled to release its second-quarter financial results before the markets open on Thursday.
The Top 4 Stocks Getting Hammered by Earnings
Despite this overall positive sentiment in the markets on Wednesday, a few companies were holding the move higher.
What Analysts Are Saying After Fitbit’s Incredible Quarter
All in all, analysts agree that Fitbit is providing exposure to the rapidly growing health and fitness wearable market and it is a company that is both highly profitable and experiencing hyper-growth.
What to Expect From Square Earnings
When Square releases its second-quarter financial results after the markets close on Wednesday, it will be one of its first few reports as a public company.
Why Sizmek Is Skyrocketing
Second-quarter financial results were ultimately driven by a huge push from the company’s core products, although this was hampered only slightly from a drop off in flash.
How 3D Systems Mixed Earnings Is Actually a Win
Quarterly revenue continued to benefit from strong demand for the company’s health care solutions and software, offset by lower demand for 3D printers and on-demand manufacturing.
Why This Is Fitbit’s Best Quarter Yet
Fitbit Inc. (NYSE: FIT) reported second-quarter financial results after the markets closed on Tuesday. The company said that it had $0.12 in earnings per share (EPS) on $587 million in revenue. There were consensus…
GameStop Moves to Expand Its Store Base Significantly
GameStop is poised to about 507 stores across the United States to its Technology Brands business.
Why Charter Could Have Most Upside of All Cable Stocks
With its acquisitions of Time Warner Cable and Bright House Networks complete, Charter Communications is the largest pure-play cable operator and the second largest broadband provider in the United States.
What to Expect From Fitbit Earnings
Fitbit is expected to report its second-quarter financial results after the markets close on Tuesday. Management had said that it is confident about the remainder of the year.
How the Seagate Earnings Win Props Up Western Digital
When Seagate Technology reported better-than-expected fiscal fourth-quarter financial results, it boosted shares of rival Western Digital as well.
How SodaStream Crushed Its Q2 Earnings
Shares of SodaStream International saw a handy gain early on Tuesday after the company completely blew out its second-quarter earnings results.
Pfizer Earnings Fail to Impress Investors
When Pfizer reported its second-quarter financial results before the markets opened on Tuesday, investors initially did not appear impressed.
What to Look for in Procter & Gamble Earnings
Procter & Gamble is scheduled to release its fiscal fourth-quarter earnings report before the markets open on Tuesday.
What to Expect From Pfizer Earnings
The upcoming earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give some insight into what companies it may be looking to pursue next.
Can Keryx Biopharma Bounce Back From This Supply Interruption?
ThinkstockShares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) sank on Monday after the company announced that there will be an interruption in the supply of Auryxia (ferric citrate) tablets due to a production-related issue converting active…